申请人:Becq Frèdèric
公开号:US20070213357A1
公开(公告)日:2007-09-13
The invention relates to the use of glycosidase inhibitors selected from compounds of general formula (1), wherein R
1
represents a CH
3
group, or CH
2
OH, R
2
represents H or an alkyl group having 1-5 carbon atoms, or R
1
and R
2
together form a group having formula (II), with carbon in position (a) and nitrogen of formula (I) mentioned above, for the preparation of a medicament used to treat mucoviscidosis.